Navigation Links
Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results
Date:8/8/2011

n 2010. The increase was primarily due to higher clinical trial costs related to multiple clinical studies, including the initiation of the Phase II study of Inovio's cervical dysplasia/cancer DNA vaccine, VGX-3100, as well as higher costs related to work performed for the NIAID HIV contract.

Net Loss Attributable to Common Stockholders The $4.8 million and $4.7 million decrease in net loss attributable to common stockholders for the three and six months ended June 30, 2011, respectively, compared with the same periods in 2010, resulted primarily from the increase in grant revenue and increase in other income from the required quarterly revaluation of registered common stock warrants, offset by the increase in research and development as well as general and administrative expenses.

Capital Resources As of June 30, 2011, cash and cash equivalents plus short-term investments in certificates of deposit were $36.4 million, compared with $21.8 million as of December 31, 2010. This change primarily resulted from the January 2011 financing, from which the Company received net proceeds of approximately $23.0 million.

Based on management's projections and analysis, the Company believes that its cash and cash equivalents are sufficient to meet its planned working capital requirements through the third quarter of 2013.

A summary of Inovio's consolidated balance sheet and statement of operations is provided at the end of this release. The Form 10-Q providing the complete 2011 second quarter financial report can be found at: http://ir.inovio.com/secfilings.

Corporate UpdateCorporate DevelopmentDuring the first quarter of 2011, Inovio announced a three-way collaboration agreement with Transgene S.A. and ChronTech Pharma AB to evaluate a novel therapeutic
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
2. Inovio Pharmaceuticals Announces Transition of Avtar Dhillon to Non-Executive Chairman of the Board
3. Inovio Pharmaceuticals to Present at Scientific & Industry Conferences
4. Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011
5. Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011
6. Inovio Pharmaceuticals Market-Leading Intellectual Property Recognized by MDB Capital Award
7. Inovio Pharmaceuticals to Present at Investor Conferences
8. Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
9. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
10. Inovio Pharmaceuticals to Present at Scientific Conferences
11. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014 The Brandeis Medical Center, led by Dr. ... a premier and affordable laser tattoo removal experience with the advanced ... is in providing high quality cosmetic services with cutting edge medical ... " Southern California has seen a dramatic increase ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
(Date:1/14/2014)... Jan. 14, 2014   Oligomerix, Inc. , a privately held ... Alzheimer,s disease (AD) and related neurodegenerative disorders, announced today ... Valhalla, NY as of January 15, 2014 ... New York Medical College. Oligomerix, which is ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... 25, 2011 Reportlinker.com announces that a new ... The 2011 Clinical Chemistry ... http://www.reportlinker.com/p0365400/The-2011-Clinical-Chemistry-Market-US-Europe-Japan.html During the ... significant transformation. The changes will be caused by ...
... of gloEMR, gloPM and gloSuite – the only ... management (PM) software with Microsoft Office built right in ... money-back guarantee ensures that doctors will be back up ... their implementation completion date or gloStream will provide a ...
Cached Medicine Technology:Reportlinker Adds The 2011 Clinical Chemistry Market: US, Europe, Japan 2gloStream Success Guarantee Ensures Doctors Will Be Back to Full Patient Load in as Little as 15 Days After EMR Implementation Completion 2gloStream Success Guarantee Ensures Doctors Will Be Back to Full Patient Load in as Little as 15 Days After EMR Implementation Completion 3
(Date:4/17/2014)... Researchers at the University of California, San Diego School ... those who have suffered a recent major loss are ... older adults. , The study is published in this ... Psychiatry . , Because compassionate behaviors are associated with ... findings offer insights into ways to improve the outcomes ...
(Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
(Date:4/17/2014)... The cause of neuronal death in Parkinson,s disease is ... may be mistaken for foreign invaders and killed by ... autoimmune diseases like type I diabetes, celiac disease, and ... published April 16, 2014, in Nature Communications . ... in Parkinson,s disease; but if true, it could lead ...
(Date:4/17/2014)... Alliance, a nonprofit organization that focuses on conservation and ... examining the current state of knowledge of the deadly ... global surveillance strategies to combat the emergence of infectious ... West Africa that has claimed the lives of 122 ... According to the World Health Organization (WHO), the deadly ...
(Date:4/17/2014)... Population Council scientists and their partners have found that ... prevent the transmission of multiple sexually transmitted infections (STIs) ... herpes simplex virus 2 (HSV-2), and human papillomavirus (HPV). ... the gel is effective against multiple strains of HIV, ... against all three viruses of at least eight hours ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... services results in, approximately $1.1 million of annualized expense reduction ... ... International,Inc. (Nasdaq: DATA ), a technology and services company focused ... of its ongoing efforts to maximize operational efficiencies, the,Company will be ...
... MISSISSAUGA, ON, June 17 /PRNewswire-FirstCall/ - Cipher,Pharmaceuticals ... New Drug,Application (NDA) for CIP-TRAMADOL ER, its extended-release ... the U.S. Food and Drug,Administration (FDA). Cipher expects ... In May 2007, the Company received an approvable ...
... BELLEVILLE, ON, June 17 /PRNewswire-FirstCall/ - Bioniche Life ... presented data regarding its E. coli O157:H7,cattle vaccine ... Mikromed 2008,in Belgrade, Serbia last weekend. The presentation ... Health Research & Development., The Bioniche vaccine ...
... NORWALK, Conn., June 17 More than half of ... most common bone disease, according,to the National Osteoporosis Foundation. ... bone loss occurs without symptoms., (Photo: http://www.newscom.com/cgi-bin/prnh/20080415/NYTUFNS1 ... it is often called, is of,particular concern to women, ...
... Clinical Professor of Dermatology at, Columbia University, hair transplant ... ( http://www.bernsteinmedical.com ) in, New York, has been chosen as one ... ... NEW YORK, June 17 Selected for his contributions in ...
... N.J., June 17 Get to soccer practice ...,finish ... of "to do" lists.,It,s no surprise many people have ... Deficit Hyperactivity Disorder (ADHD) too, the,disorder can make it ... ADHD affects 8.7 percent of children in the U.S., ...
Cached Medicine News:Health News:Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies 2Health News:Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies 3Health News:Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies 4Health News:Cipher's revised NDA for CIP-TRAMADOL ER accepted for review by FDA 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Osteoporosis and Bone Health 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Osteoporosis and Bone Health 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Osteoporosis and Bone Health 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Osteoporosis and Bone Health 5Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Osteoporosis and Bone Health 6Health News:Hair Restoration Surgeon named NYC 'Best Doctor' for 9 Years in a Row 2Health News:Organizing Tips for the ADHD Family 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: